newsfilter
← Latest News
GlobeNewswire·

OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference

  • OnKure Therapeutics (NASDAQ: OKUR) announced senior management will attend the Morgan Stanley 24th Annual Global Healthcare Conference.
  • The conference is scheduled to take place in New York from September 14 – 16, 2026.
  • The management team will host one-on-one meetings with investors during the event.
  • Interested investors must contact their Morgan Stanley representative to schedule meetings.
  • OnKure is a clinical-stage biopharmaceutical company developing precision medicines for vascular anomalies & cancers.
  • The company uses a structure & computational chemistry-driven drug design platform to create small molecule drugs.
  • OnKure aims to lead in targeting PI3Kα with multiple programs designed for best-in-class outcomes.
  • For more information, investors can visit www.onkure.com, follow OnKure on LinkedIn, or contact Dan Ferry at LifeSci Advisors.